Corient Private Wealth
COLL icon

Corient Private Wealth’s Collegium Pharmaceutical COLL Stock Holding History

Corient Private Wealth’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.6M Buy
71,870
+27,097
+61% +$926K ﹤0.01% 1226
2026
Q1 		$1.48M Buy
44,773
+36,907
+469% +$1.56M ﹤0.01% 1421
2025
Q4 		$364K Buy
7,866
+858
+12% +$35.9K ﹤0.01% 2044
2025
Q3 		$245K Buy
+7,008
New +$244K ﹤0.01% 2245

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Corient Private Wealth's COLL Position: Q2 2026 in Review

Corient Private Wealth increased its Collegium Pharmaceutical (COLL) stake by 61% in Q2 2026, buying an estimated $926K and bringing the position to 71,870 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1226.

Corient Private Wealth first reported a position in COLL in Q3 2025 and has held it in 4 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Corient Private Wealth held 71,870 shares of Collegium Pharmaceutical worth $2.6M as of Q2 2026.
  • Corient Private Wealth bought 27,097 Collegium Pharmaceutical shares in Q2 2026, an estimated $926K.
  • Collegium Pharmaceutical made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1226 holding.
  • Corient Private Wealth first reported a position in Collegium Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.